Ligand validation:5SBN

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5SBN_EDO_A_206	25%	75%	0.193	0.829	0.61	0.38	-	-	0	0	100%	1
5SBN_EDO_A_205	13%	70%	0.279	0.819	0.51	0.64	-	-	0	0	100%	0.5
5SBP_EDO_A_206	65%	75%	0.102	0.904	0.65	0.33	-	-	0	0	100%	1
5SC0_EDO_A_206	39%	80%	0.184	0.891	0.07	0.75	-	-	2	0	100%	1
5SBO_EDO_A_206	39%	82%	0.19	0.896	0.27	0.52	-	-	0	0	100%	1
5SC5_EDO_A_204	38%	80%	0.186	0.886	0.73	0.14	-	-	3	0	100%	0.5
5SBW_EDO_A_207	36%	91%	0.218	0.913	0.25	0.31	-	-	1	0	100%	1
5EGE_EDO_A_505	100%	84%	0.019	0.997	0.5	0.26	-	-	0	0	100%	1
4Q6J_EDO_B_305	100%	83%	0.024	0.997	0.53	0.26	-	-	2	0	100%	1
4NMU_EDO_C_206	100%	80%	0.021	0.994	0.43	0.41	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
3DPJ_EDO_B_195	100%	82%	0.021	0.994	0.47	0.34	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.